Blue-Green Algae (Cyanobacteria)
Authors:
- Wayne CarmichaelWCWayne Carmichael
- Mary StukenbergMSMary Stukenberg
- 25 June 2010
- book chapter
- Published by Taylor & Francis
- p. 75-81
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- First detection of anatoxin-a in human and animal dietary supplements containing cyanobacteriaFood and Chemical Toxicology, 2009
- Liquid Chromatographic Determination of the Cyanobacterial Toxin β-N-Methylamino-L-Alanine in Algae Food Supplements, Freshwater Fish, and Bottled WaterJournal of Food Protection, 2009
- Mobilization of human CD34+CD133+ and CD34+CD133− stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae—related to modulation of CXCR4 expression by an L-selectin ligand?Cardiovascular Revascularization Medicine, 2007
- Nutrition rehabilitation of undernourished children utilizing Spiruline and MisolaNutrition Journal, 2006
- A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndromeAmerican Journal of Ophthalmology, 2004
- Hypocholesterolemic Effect of Spirulina in Patients with Hyperlipidemic Nephrotic SyndromeJournal of Medicinal Food, 2002
- Commercial production of microalgae in the Asia-Pacific rimJournal of Applied Phycology, 1997
- Spirulina industry in China: Present status and future prospectsJournal of Applied Phycology, 1997
- THE BIOCHEMISTRY AND INDUSTRIAL POTENTIAL OF SPIRULINAAnnual Review of Microbiology, 1985
- Production and utilization of the blue-green alga Spirulina in IndiaBiomass, 1984